Project Grant HT94252410024
Award Date
1/15/24
Completion Date
1/14/26
Dollars Obligated
$394K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98105, USA
Similar Awards
This $2,112,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the Fred Hutchinson Cancer Center in Seattle, Washington to prevent liver metastasis by defining regulators of tumor dormancy, understanding how they are disrupted, and developing strategies to reverse it. The research aims to transform healthcare for military service members and the broader public through innovative and impactful...
The Children's Research Institute received a $709,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research efforts from May 2021 through April 2024 to enhance T-cell immunotherapy treatments for pediatric patients with relapsed or refractory solid tumors. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
This Project Grant award, valued at $1,067,418.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research by The Children's Hospital Corporation (doing business as Boston Children's Hospital) to activate gasdermin pores and induce pyroptosis, with the goal of enhancing antitumor immunity in ovarian cancers. The research will be conducted over a 3-year period from April 2025 to April 2028. As a...
The Department of the Army Medical Command awarded a $5,753,844 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to the Portland VA Research Foundation, Inc. for the period of July 1, 2022 to June 30, 2026. The grant will support the preclinical development of novel liver-stage active antimalarial drugs with radical cure potential. Through innovative research, the goal is to transform healthcare for service members and the public by...
The Department of Defense's Defense Health Agency awarded a $3,188,604 Project Grant titled "USE OF HIGH-THROUGHPUT SEQUENCING OF THE IMMUNOGLOBULIN LOCI FOR REFINED RISK STRATIFICATION IN PEDIATRIC B-ALL" to Seattle Children's Hospital, doing business as Seattle Children's Research Institute. This grant, funded through the Military Medical Research and Development (CFDA 12.420) program, supports biomedical research related to military medicine, with a focus on cancer, neurological...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The Department of the Army Medical Command awarded a $544,250 Project Grant to the University of Washington under the Military Medical Research and Development program (CFDA 12.420) to identify epigenetic-based targets against cancer stem cells in rhabdomyosarcoma. The three-year award beginning August 1, 2022 will support research to investigate medical solutions for battlefield injuries by exploring innovative biomedical research approaches. Specifically, the University of Washington will...
The Defense Health Agency awarded a $528,000 Project Grant to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to assess the landscape of cell surface targets in metastatic prostate cancer. This 2-year grant, which began on April 15, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420). The project aims to advance biomedical research on innovative therapeutic approaches for cancer, in line with the program's goals of...